Low molecular weight heparin or semuloparin should not be recommended for thromboprophylaxis in ambulatory solid cancer patients undergoing chemotherapy.
作者信息
Oo Thein H
出版信息
Thromb Res. 2012 Nov;130(5):821-2. doi: 10.1016/j.thromres.2012.07.026. Epub 2012 Aug 24.
Abstract
摘要
Zotero 插件